Anumigilimab

• CAT Number: I042174
• CAS Number: 2416593-08-1
• Purity: ≥95%

Anumigilimab (CSL-324) is an human IgG2a mAb against human granulocyte colony-stimulating factor (G-CSF) receptor. Anumigilimab can be used for increasing numbers of neutrophils at sites of inflammation[1][2].

Reference

[1]. Markota Čagalj A, et al. New and Emerging Targeted Therapies for Hidradenitis Suppurativa. Int J Mol Sci. 2022 Mar 29;23(7):3753.
 [Content Brief]

[2]. Rosales Santillan M, et al. Biologic therapies for the treatment of hidradenitis suppurativa. Expert Opin Biol Ther. 2020 Jun;20(6):621-633.
 [Content Brief]